《2022年美国肝病学会实践指南:肝硬化失代偿期的症状管理和姑息性治疗》摘译

2022-04-14 梅州市人民医院 临床肝胆病杂志

姑息性治疗的好处逐渐受到各种疾病状态以及肝硬化失代偿期患者的认可。肝硬化的各个阶段均可行姑息性治疗,但该指南主要适用于肝硬化失代偿期的成年患者,因为这类人群承受着相当大的身体、社会心理和经济负担。该指

中文标题:

《2022年美国肝病学会实践指南:肝硬化失代偿期的症状管理和姑息性治疗》摘译

发布机构:

梅州市人民医院

发布日期:

2022-04-14

简要介绍:

姑息性治疗的好处逐渐受到各种疾病状态以及肝硬化失代偿期患者的认可。肝硬化的各个阶段均可行姑息性治疗,但该指南主要适用于肝硬化失代偿期的成年患者,因为这类人群承受着相当大的身体、社会心理和经济负担。该指南[1]是在美国肝病学会(AASLD)实践指南委员会的支持和监督下制定的,现将指南实践指导性声明摘译如下。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=《2022年美国肝病学会实践指南:肝硬化失代偿期的症状管理和姑息性治疗》摘译.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d5c391c002a142e2, title=《2022年美国肝病学会实践指南:肝硬化失代偿期的症状管理和姑息性治疗》摘译, enTitle=, guiderFrom=临床肝胆病杂志, authorId=0, author=, summary=姑息性治疗的好处逐渐受到各种疾病状态以及肝硬化失代偿期患者的认可。肝硬化的各个阶段均可行姑息性治疗,但该指南主要适用于肝硬化失代偿期的成年患者,因为这类人群承受着相当大的身体、社会心理和经济负担。该指, cover=https://img.medsci.cn/20220415/1650034716913_5579292.png, journalId=0, articlesId=null, associationId=2623, associationName=梅州市人民医院, associationIntro=梅州市人民医院(梅州市医学科学院)消化内科, copyright=0, guiderPublishedTime=Thu Apr 14 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">姑息性治疗的好处逐渐受到各种疾病状态以及肝硬化失代偿期患者的认可。肝硬化的各个阶段均可行姑息性治疗,但该指南主要适用于肝硬化失代偿期的成年患者,因为这类人群承受着相当大的身体、社会心理和经济负担。该指南[1]是在美国肝病学会(AASLD)实践指南委员会的支持和监督下制定的,现将指南实践指导性声明摘译如下。&nbsp;</span></p>, tagList=[TagDto(tagId=492, tagName=肝硬化), TagDto(tagId=49415, tagName=失代偿期肝硬化)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3437, appHits=114, showAppHits=0, pcHits=420, showPcHits=3323, likes=0, shares=26, comments=3, approvalStatus=1, publishedTime=Sat Apr 16 15:22:00 CST 2022, publishedTimeString=2022-04-14, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Apr 15 22:58:13 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 18:55:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《2022年美国肝病学会实践指南:肝硬化失代偿期的症状管理和姑息性治疗》摘译.pdf)])
《2022年美国肝病学会实践指南:肝硬化失代偿期的症状管理和姑息性治疗》摘译.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1223004, encodeId=df931223004c0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12816530333, createdName=ms4000001551689929, createdTime=Sat May 28 16:28:16 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212797, encodeId=ac0f1212e97c1, content=👌, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=010e8125542, createdName=ms5000000872057228, createdTime=Wed Apr 20 10:42:30 CST 2022, time=2022-04-20, status=1, ipAttribution=)]
    2022-05-28 ms4000001551689929

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1223004, encodeId=df931223004c0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12816530333, createdName=ms4000001551689929, createdTime=Sat May 28 16:28:16 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212797, encodeId=ac0f1212e97c1, content=👌, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=010e8125542, createdName=ms5000000872057228, createdTime=Wed Apr 20 10:42:30 CST 2022, time=2022-04-20, status=1, ipAttribution=)]
    2022-04-20 ms5000000872057228

    👌

    0